Advertisement

Topics

Evotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge

02:51 EST 15 Feb 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and MaRS Innovation announced today that they have identified the first project to be developed under their LAB150 partnership. After signing a colla...

Other Sources for this Article

Evotec AG:
Gabriele Hansen
VP Corporate Communications & Investor Relations
Phone: +49.(0)40.56081-255
gabriele.hansen@evotec.com

NEXT ARTICLE

More From BioPortfolio on "Evotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge"

Advertisement
Quick Search
Advertisement
Advertisement